ADC Therapeutics

ADCTNYSE Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$143.726 M

$1.13 +0.00%

Close of 7 Aug 2026

Revenue

$81.4M

#2590 by revenue

Earnings

-$142.6M

Loss-making

Shares outstanding

127,191,158

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#283Milestone PharmaceuticalsMIST$151.9M
#284Canton StrategicCNTN$144.2M
#285ADC TherapeuticsADCT$143.7M
#286Nervgen PharmaNGEN$140.6M
#287Organigram GlobalOGI$139.4M

Where these numbers come from

Share counts and financials for ADC Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.